Johnson & Johnson recently announced a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, based in South Africa.
The companies will work towards a...
CVS Health recently announced several initiatives to boost affordable healthcare and increase access to medicine for customers.
First, the company named Prem Shah to the newly created role of...
Pfizer and Amazon Web Services (AWS) recently collaborated to create innovative, cloud-based solutions to improve drug development, manufacturing, and distribution for clinical trials.
The...
Novo Nordisk recently entered into a pharma acquisition deal with Dicerna Pharmaceuticals to increase its pipeline of RNAi therapies and technology platforms.
Dicerna develops RNAi-based...
Moderna recently dosed the first participant in the Phase 2/3 study of its mRNA respiratory syncytial virus (RSV) vaccine candidate.
mRNA-1345 is an RSV vaccine for a prefusion F glycoprotein,...
FDA recently approved Voxzogo injection for children five years of age and older with achondroplasia and open epiphyses.
Achondroplasia is the most common form of dwarfism. Individuals living...
Gilead recently added three programs in Arcus Biosciences’ clinical-stage portfolio, including antibodies and small molecules, to its oncology pipeline.
Specifically, Gilead exercised its...
The US government recently purchased 10 million courses of Pfizer’s COVID-19 antiviral candidate, PAXLOVID.
Under the terms of the agreement, the government will acquire 10 million...
Moderna recently announced that its mRNA therapeutic for heart failure patients undergoing coronary artery bypass grafting (CABG) surgery met its primary endpoint in a Phase 2 study.
The...
FDA recently expanded the emergency use authorization (EUA) for a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include individuals 18 years of age and older.
Caregivers can administer the...
FDA recently approved PharmaEssentia’s injection to treat adults with polycythemia vera, a rare blood disease that causes overproduction of red blood cells.
The monopegylated, long-acting...
Pfizer, BioNTech, and instant logistics company, Zipline, collaborated to deliver authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana.
The companies recently developed and...
Pfizer and Biohaven Pharmaceuticals recently collaborated to commercialize rimegepant, a generic drug used to treat migraine attacks, in markets outside of the US.
Commercialized as Nurtec ODT in the...
GSK recently announced that its drug, daprodustat, was safe and effective in patients with anemia due to chronic kidney disease (CKD).
The Phase 3 ASCENT trial studied the hypoxia-inducible...
Merck and Ridgeback Biotherapeutics recently announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) authorized their COVID-19 treatment for adults.
The UK’s...
FDA recently approved Novartis’ Scemblix to treat chronic myeloid leukemia (CML) for adult and pediatric patients with Philadelphia chromosome-positive CML in chronic phase.
Scemblix is the...
The CDC Advisory Committee on Immunization Practices (ACIP) recently recommended Pfizer and BioNTech’s pediatric COVID-19 vaccine for children five to 11 years of age.
The organization now...
Eli Lilly and Company recently announced that tirzepatide elicited superior A1C and body weight reductions from baseline in adults with type 2 diabetes with increased cardiovascular risk.
Data...
FDA recently granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for children five through 11 years of age.
The agency based its decision on data from a Phase 2/3...
FDA recently approved a new low-dose tablet dosage form of Gilead’s HIV-1 drug, Biktarvy, in pediatric patients.
The agency approved the new dosage for children weighing at least 30 pounds who...
